Latest Breaking News On - Cancer annual congress - Page 1 : comparemela.com

Arvinas, Pfizer Update Phase 1b Trial Data for Vepdegestrant, Palbociclib

Arvinas, Pfizer Update Phase 1b Trial Data for Vepdegestrant, Palbociclib
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesNoah berkowitzRoger danseyArvinas incBreast cancer researchBreast cancer annual congressDrug administrationSarah cannon research institute in nashvilleBreast cancer research executive committeePfizer incEuropean society for medical oncologySan antonio breast cancer symposiumMedical oncologyBreast cancer annualChief medical officerChief development officer

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJeff boyleRoger danseyNoah berkowitzKathleen murphyBreast cancer annual congressSarah cannon research institute in nashvilleExchange commissionBreast cancer researchArvinas incPfizer incDrug administrationBreast cancer research executive committeeEuropean society for medical oncologyPfizer announce updated clinical data

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE)

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkKathleen murphyRoger danseyJeff boyleNoah berkowitzExchange commissionBreast cancer research executive committeeDrug administrationBreast cancer researchBreast cancer annual congressEuropean society for medical oncologyArvinas incSarah cannon research institute in nashvillePfizer incSan antonio breast cancer symposium

Vepdegestrant Plus Palbociclib Sustains Efficacy in Advanced ER+ Breast Cancer

Vepdegestrant plus palbociclib maintained clinical efficacy and safety in patients with pretreated, advanced ER-positive, HER2-negative breast cancer.

United statesRoger danseyNoah berkowitzPalbociclib ibranceArvinas incBreast cancer annual congressCancer annualBreast cancer research executive committeeSarah cannon research instituteCancer annual congressHuman epidermal growth

Olema Oncology Announces Promising New Data for

Olema Oncology Announces Promising New Data for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesUnited kingdomGeoffrey mogilnerSeanp bohenCompany investor webcastExchange commissionBreast cancer annual congressDrug administrationOlema pharmaceuticals incSecurities exchangeCancer annual congressEstrogen receptor positiveHuman epidermal growth factor receptorMetastatic breastChief executive officer